Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03396445
Title Safety and Pharmacokinetics Study of MK-5890 as Monotherapy and in Combination With Pembrolizumab (MK-3475) in Adults With Advanced Solid Tumors (MK-5890-001)
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Merck Sharp & Dohme Corp
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA | NLD | ESP

Facility Status City State Zip Country Details
University of South Alabama, Mitchell Cancer Institute ( Site 0020) Mobile Alabama 36604 United States Details
Florida Cancer Specialists ( Site 0002) Sarasota Florida 34232 United States Details
The West Clinic, P.C. ( Site 0021) Germantown Tennessee 38138 United States Details
FALP-UIDO ( Site 0502) Santiago Region M. De Santiago 6900941 Chile Details
Bradfordhill-Clinical Area ( Site 0501) Santiago Region M. De Santiago 8420383 Chile Details
Soroka Medical Center-Oncology ( Site 0012) Be'er Sheva 8400000 Israel Details
Hadassah Ein Kerem Medical Center ( Site 0010) Jerusalem 9112001 Israel Details
The Chaim Sheba Medical Center - Oncology Institute ( Site 0001) Ramat Gan 5265601 Israel Details
Seoul National University Hospital-Internal Medicine ( Site 0702) Seoul 03080 Korea, Republic of Details
Severance Hospital, Yonsei University Health System-Medical oncology ( Site 0701) Seoul 03722 Korea, Republic of Details
Antoni van Leeuwenhoek Ziekenhuis ( Site 0003) Amsterdam Noord-Holland 1066 CX Netherlands Details
Erasmus MC ( Site 0031) Rotterdam Zuid-Holland 3015 GD Netherlands Details
Hospital Universitario Quiron Madrid ( Site 0043) Pozuelo de Alarcon Madrid 28223 Spain Details
Instituto Catalan de Oncologia - ICO ( Site 0044) Barcelona 08916 Spain Details
Hospital Universitario Fundacion Jimenez Diaz ( Site 0041) Madrid 28040 Spain Details
Centro Integral Oncologico Clara Campal START Madrid ( Site 0040) Madrid 28050 Spain Details
National Taiwan University Hospital-Oncology ( Site 0801) Taipei 100 Taiwan Details
Koo Foundation Sun Yat-Sen Cancer Center ( Site 0802) Taipei 112 Taiwan Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field